Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM PAR
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
670,720
-
Shares change
-
-341,640
-
Total reported value, excl. options
-
$3,166,000
-
Value change
-
-$1,250,255
-
Number of buys
-
9
-
Number of sells
-
-6
-
Price
-
$4.72
Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q2 2020
24 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q2 2020.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 670,720 shares
.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (137,672 shares), VANGUARD GROUP INC (93,381 shares), OVERBROOK MANAGEMENT CORP (88,025 shares), PERRITT CAPITAL MANAGEMENT INC (60,000 shares), MORGAN STANLEY (59,066 shares), SHUFRO ROSE & CO LLC (50,670 shares), Strategic Financial Services, Inc, (30,028 shares), HM PAYSON & CO (29,500 shares), GEODE CAPITAL MANAGEMENT, LLC (20,434 shares), and BlackRock Inc. (18,375 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.